Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on SMIA. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101538255B details a greener synthesis for SMIA using butyl acetate, reducing solvent loss and byproducts for reliable pharmaceutical intermediate supply.
Patent CN105254603A reveals optimized SMIA synthesis. Reduces trans-isomers, improves purity. Ideal for cephalosporin production supply chains.